Clinical Trials Logo

Clinical Trial Summary

The main goal of this study is to improve dysexecutive symptoms (e.g., sustained attention, processing speed) in patients exhibiting post-acute sequelae of COVID-19 (PASC) through home-based transcranial direct current stimulation (tDCS), a noninvasive method that uses low intensity electric currents delivered to the brain through stimulation electrodes on the scalp.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05092516
Study type Interventional
Source Massachusetts General Hospital
Contact Hamdi Eryilmaz, Ph.D.
Phone 6176437462
Email hamdi.eryilmaz@mgh.harvard.edu
Status Recruiting
Phase N/A
Start date June 7, 2022
Completion date August 31, 2024